Abstract:Colon cancer is a common type of cancer worldwide and accounts for a significant number of cancer-related deaths. Although surgical techniques and treatment strategies for colon cancer have advanced over the past two decades, the prognosis has not improved considerably. Resveratrol, a natural stilbene compound, possesses antioxidant, cardioprotective and anticancer properties. However, the role of resveratrol in colon cancer has not been fully elucidated. The present study demonstrated that resveratrol inhibited cell proliferation and colony growth in DLD1 and HCT15 colon cancer cells, but did not affect normal colon epithelial cells. The resveratrol-mediated inhibition of cell proliferation correlated with an induction of apoptosis and with G(1) phase cell cycle arrest in colon cancer cells. Additionally, resveratrol treatment decreased the protein expression levels of cyclin D1, cyclin E2 and BCL2 apoptosis regulator, while it increased BCL2 associated X and tumor protein p53, all of which are involved in the regulation of cell cycle and apoptosis. Notably, the results obtained from in silico computational screening identified AKT serine/threonine kinase 1 (AKT1) and AKT2 as novel targets of resveratrol. Computational docking suggested that there are three or four possible hydrogen bonds in the active pocket of AKT1 and AKT2 that contribute to the mode of action of resveratrol. The present study confirmed that resveratrol bound to AKT1 and AKT2 with a pull-down assay. Furthermore, knockdown of AKT1 and AKT2 inhibited cell proliferation and colony growth, by attenuating cell cycle progression and increasing apoptosis in colon cancer cells, effects that were similar to those caused by resveratrol treatment. Taken together, the present results suggest that the targeting effects of resveratrol to AKT1 and AKT2 may be a potent strategy for chemoprevention or therapy for colon cancer.

Resveratrol inhibits proliferation in human colorectal carcinoma cells by inducing G1/S-phase cell cycle arrest and apoptosis through caspase/cyclin-CDK pathways

Effect of Proliferation, Cell Cycle, and Bcl-2s of MCF-7 Cells by Resveratrol

Resveratrol inhibits proliferation, angiogenesis and induces apoptosis in colon cancer cells

Resveratrol Treatment Inhibits Proliferation of and Induces Apoptosis in Human Colon Cancer Cells

Resveratrol affects protein kinase C activity and promotes apoptosis in human colon carcinoma cells.

Molecular mechanism of resveratrol inhibiting proliferation of human lung cancer cells through inducing cell cycle arrest and apoptosis

Resveratrol Inhibits Oral Squamous Cell Carcinoma Through Induction of Apoptosis and G2/M Phase Cell Cycle Arrest.

Effects of resveratrol on cell cycle regulatory processes of human lung adenocarcinoma A549 cells and its mechanism

Resveratrol-induced cell inhibition of growth and apoptosis in MCF7 human breast cancer cells are associated with modulation of phosphorylated akt and caspase-9

Resveratrol Suppresses Colon Cancer Growth by Targeting the AKT/STAT3 Signaling Pathway.

Resveratrol inhibits proliferation of colorectal cancer SW480 cells by increasing miR-34c expression

Anti-proliferation effect of resveratrol and p38 MAPK in human colon cancer cells

Experimental Study on the Effect of Resveratrol on Cell Cycle of HepG2 Cells

Resveratrol Inhibits Invasion and Metastasis of Hepatocellular Carcinoma Cells

Resveratrol inhibits the phosphatidylinositide 3-kinase/protein kinase B/mammalian target of rapamycin signaling pathway in the human chronic myeloid leukemia K562 cell line

[Effects of Resveratrol on Growth Inhibition and Gap-Junctional Intercellular Communication of HepG2 Cells].

Resveratrol confers resistance against taxol via induction of cell cycle arrest in human cancer cell lines.

Resveratrol regulates cellular PKC alpha and delta to inhibit growth and induce apoptosis in gastric cancer cells

Resveratrol Induced Apoptosis and Cell Arrest in Cancer Cells

Resveratrol induces AMPK-dependent MDR1 inhibition in colorectal cancer HCT116/L-OHP cells by preventing activation of NF-κB signaling and suppressing cAMP-responsive element transcriptional activity

Preliminary studies on effects of resveratrol in inhibiting growth of HepG2 and inducing its apoptosis